Fatty liver index as an indicator of metabolic syndrome

被引:26
|
作者
Rogulj, Dinko [2 ]
Konjevoda, Pasko [3 ]
Milic, Mirta [4 ]
Mladinic, Marin [4 ]
Domijan, Ana-Marija [1 ]
机构
[1] Univ Zagreb, Fac Pharm & Biochem, Zagreb 10000, Croatia
[2] Polyclin Sunce, Zagreb, Croatia
[3] Rudjer Boskovic Inst, NMR Ctr, Zagreb, Croatia
[4] Inst Med Res & Occupat Hlth, Mutagenesis Unit, Zagreb 41000, Croatia
关键词
Fatty liver index; Metabolic syndrome; Oxidative stress; REPTree and SimpleCART algorithms; ROC curve analysis; C-REACTIVE PROTEIN; COMET ASSAY; DNA-DAMAGE; GAMMA-GLUTAMYLTRANSFERASE; OXIDATIVE DAMAGE; NATIONAL-HEALTH; ASSOCIATION; MARKERS; OBESITY; REPAIR;
D O I
10.1016/j.clinbiochem.2011.10.014
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: The aim of this study was to find an early indicator of metabolic syndrome (MetS). Design and methods: We measured several anthropometric, biochemical, haematological, and oxidative damage parameters in 128 middle-aged Caucasian men divided into two groups: patients with MetS (n=69) and healthy controls (n=59), and used Weka REPTree and SimpleCART algorithms to identify the most reliable predictor of MetS. Results: Oxidative damage parameters did not differ between the groups, suggesting that oxidative damage is less prominent at the early stage of MetS. The algorithms singled out fatty liver index (FLI) as the best variable for discriminating between healthy and MetS subjects. This finding was confirmed by the receiver-operating characteristic (ROC) curve analysis, which set FLI 68.53 as the threshold value for MetS diagnosis. Conclusions: FLI is the most reliable tool for diagnosing MetS. The absence of oxidative damage does not rule out oxidative stress but may indicate that MetS is at an early stage. (C) 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:68 / 71
页数:4
相关论文
共 50 条
  • [1] Fatty liver and the metabolic syndrome
    Neuschwander-Tetri, Brent A.
    CURRENT OPINION IN GASTROENTEROLOGY, 2007, 23 (02) : 193 - 198
  • [2] Fatty liver and metabolic syndrome
    Tor, Jordi
    Muga, Roberto
    MEDICINA CLINICA, 2013, 141 (06): : 252 - 253
  • [3] Evaluation of Hepatic Steatosis by Fatty Liver Index and Metabolic Syndrome in a Young Population
    Musso, Carla
    Graffigna, Mabel
    Soutelo, Jimena
    Aran-Guren, Marcela
    Salgado, P.
    Azpelicueta, A.
    Perel, Cecilia
    Catoira, Natalia
    Migliano, M.
    Garro, M. P.
    Farias, Javier M.
    Berg, Gabriela
    DIABETES, 2016, 65 : A409 - A409
  • [4] Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease
    Cheng, Yuan-Lung
    Wang, Yuan-Jen
    Lan, Keng-Hsin
    Huo, Teh-Ia
    Huang, Yi-Hsiang
    Su, Chien-Wei
    Hsieh, Wei-Yao
    Hou, Ming-Chih
    Lin, Han-Chieh
    Lee, Fa-Yauh
    Wu, Jaw-Ching
    Lee, Shou-Dong
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2017, 2017
  • [5] Fatty liver, hypertension, and the metabolic syndrome
    Diehl, AM
    GUT, 2004, 53 (07) : 923 - 924
  • [6] Prevalence of fatty liver in metabolic syndrome
    Goyal, Anita
    Arora, Hobinder
    Arora, Sumit
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (07) : 3246 - 3250
  • [7] Validation of Fatty Liver Index and Lipid Accumulation Product for Identifying Nonalcoholic Fatty Liver Disease in Asian Population With Metabolic Syndrome
    Phisalprapa, Pochamana
    Ujjin, Anunya
    Apisarnthanarak, Piyaporn
    Charoensak, Aphinya
    Washirasaksiri, Chaiwat
    Srivanichakorn, Weerachai
    Pandejpong, Denla
    Charatcharoenwitthaya, Phunchai
    GASTROENTEROLOGY, 2014, 146 (05) : S947 - S947
  • [8] THE SNORING INDEX AS AN INDICATOR FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH SLEEP APNOEA SYNDROME
    Bahr, K.
    Simon, P.
    Schattenberg, J.
    Gouveris, H.
    SLEEP MEDICINE, 2022, 100 : S285 - S285
  • [9] Management of fatty liver disease with the metabolic syndrome
    Machado, Mariana Verdelho
    Cortez-Pinto, Helena
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (05) : 487 - 500
  • [10] Nonalcoholic fatty liver disease and the metabolic syndrome
    Marchesini, G
    Marzocchi, R
    Agostini, F
    Bugianesi, E
    CURRENT OPINION IN LIPIDOLOGY, 2005, 16 (04) : 421 - 427